Veronica Bergottini | Bacterial cellulose biomaterials | Best Researcher Award

Veronica Bergottini | Bacterial cellulose biomaterials | Best Researcher Award

VerĆ³nica Bergottini, Ph.D., is a distinguished scientist and professor specializing in Biological Sciences. She earned her Ph.D. from the University of NeuchĆ¢tel, Switzerland, in 2015, focusing on the role of native Plant Growth Promoting Rhizobacteria (PGPR) associated with Yerba Mate (Ilex paraguariensis). Her research aimed to assess their potential as bio-inoculants for this vital crop. Earlier, she obtained a B.Sc. in Genetics from the National University of Misiones, Argentina, where her work centered on genetic diversity, molecular taxonomy, and symbiotic efficiency of rhizobia populations.

Currently serving as a Professor-Scientist at the Laboratory of Environmental Biotechnology since April 2018 at Universidad Argentina de la Empresa (UADE), Dr. Bergottini imparts knowledge in General Microbiology, Ecology for Environmental Management, and Biotechnology for Agricultural Management. Her commitment to advancing scientific understanding and education is commendable. šŸŒæšŸ”¬

profile

springer

Scopus

Education šŸ“ššŸŒ±

Dr. VerĆ³nica Bergottini embarked on her academic journey with a Ph.D. in Biological Sciences from the University of NeuchĆ¢tel, Switzerland (Sep. 2013 – May 2015). Her dissertation delved into the intricate task of evaluating the role of native Plant Growth Promoting Rhizobacteria (PGPR) associated with Yerba Mate (Ilex paraguariensis) as bio-inoculants for this crucial crop. Prior to her doctoral studies, she earned a B.Sc. in Genetics from the National University of Misiones, Argentina, focusing on the genetic diversity, molecular taxonomy, and symbiotic efficiency of rhizobia populations that nodulate Lotus tenuis.

Her academic journey began at Hindenburg Schule in Eldorado, Misiones, for Primary and Secondary School education. Dr. Bergottini’s research contributions and dedication to scientific exploration underscore her commitment to advancing our understanding of plant-microbe interactions. šŸŒšŸ”¬

Experience

Dr. VerĆ³nica Bergottini is a distinguished Professor-Scientist at the Laboratory of Environmental Biotechnology, Universidad Argentina de la Empresa (UADE) since April 2018. Her impactful courses include General Microbiology for Biotech and Food Engineers (2018-2022), Ecology for Environmental Management (2018-2022), and Biotechnology for Agricultural Management (2018-2023).

Adding to her academic repertoire, Dr. Bergottini assumed the role of Professor in Biomaterials and Design at Universidad Torcuato Di Tella, Argentina, starting April 2022. Simultaneously, she has been instrumental in the production of Kombucha and Research + Development in Biomaterials at Karu Fermentos since March 2018.

Her entrepreneurial spirit shone as she served as the Laboratory Responsible at Kwell levaduras from February 2017 to January 2018. Additionally, she contributed as a Doctoral Assistant in Microbiology at the University of Neuchatel, Switzerland, from Sep. 2014 to May 2015. Dr. Bergottini’s diverse roles reflect her dedication to fostering knowledge and innovation. šŸŒ±šŸ”¬

Achievements & Recognitions šŸ†šŸŒ

Dr. VerĆ³nica Bergottini stands as an Ambassador of the PROESUS Program in 2020 and held the esteemed position of National Minister of Environment in 2019, showcasing her dedication to environmental causes.

Her entrepreneurial spirit earned her the prestigious Innovar Award in the Entrepreneur category in 2019. Dr. Bergottini was a Finalist of the WISE Awards (Women in STEM) at IAE in the same year, emphasizing her contributions to the fields of science, technology, engineering, and mathematics.

Acknowledged as a Semifinalist of NAVES NACIONAL ā€“IAE 2019 and a Finalist of the Talent Brother Awards in Sustainable Fashion Edition EAMODA 2017, she has consistently demonstrated her commitment to innovation and sustainability.

Dr. Bergottini’s academic prowess is evident through her receipt of an academic prize for her PhD thesis at the Faculty of Sciences, University of NeuchĆ¢tel in 2015. Additionally, she was a recipient of the Swiss Government Excellence Scholarships for Foreign Scholars during her research internship from 2011-2013. Earlier, she received scholarships from the ComitĆ© Ejecutivo de Desarrollo e InnovaciĆ³n (CEDIT) and the Agencia Nacional de PromociĆ³n CientĆ­fica y TecnolĆ³gica for her research endeavors. šŸŒŸšŸ”¬

 

Publications Top NotesĀ 

 

 

Herbert Meltzer | Schizophrenia | Best Scholar Award

Herbert Meltzer | Schizophrenia | Best Scholar Award

šŸ‘Øā€āš•ļø Prof. Herbert Y. Meltzer, M.D., is a distinguished psychiatrist currently affiliated with Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. His office is located at 303 East Chicago Avenue, Ward Bldg 7-101, and 680 N. Lakeshore Prof. Suite 1520, Chicago, IL 60611.

šŸŽ“ Prof. Meltzer’s academic journey began at Cornell University, where he earned his B.A. with honors in 1958. He continued his education with an M.A. at Harvard University in 1959 and obtained his M.D. from Yale University in 1963, accompanied by a Certificate in Community Psychiatry. Committed to advancing mental health, he participated in the Associate Faculties Program in Community Psychiatry at the Washington School of Psychiatry from 1966 to 1968.

šŸ† Prof. Meltzer’s extensive contributions to psychiatry and academic excellence underscore his impact on the field. His current association with Northwestern University reflects a continued dedication to advancing psychiatric research and education. šŸŒšŸ§ 

Profile

scopus

pubmed

x-mol

researchgate

Education

šŸŽ“ Prof. Herbert Y. Meltzer’s academic journey is marked by excellence. He earned his B.A. from Cornell University in 1958, showcasing early academic prowess. Subsequently, he pursued an M.A. at Harvard University in 1959 and achieved an M.D. from Yale University in 1963. His commitment to community psychiatry is evident through his Certificate in Community Psychiatry and participation in the Associate Faculties Program in Community Psychiatry at the Washington School of Psychiatry from 1966 to 1968. Prof. Meltzer’s educational trajectory reflects a dedication to advancing mental health knowledge and practice. šŸ«šŸ“ššŸ‘Øā€āš•ļø

Honors and Awards

šŸŽ“ Dr. Herbert Y. Meltzer, an esteemed figure in the field of chemistry and neuropsychopharmacology, graduated with distinction and honors in chemistry from Cornell University. His academic journey is adorned with prestigious accolades, including the Phi Beta Kappa honor, New York State Regent’s and Cornell University Scholarships, the Dean’s Scholarship at Cornell, the Telluride Associate Scholarship, and the George Chapman Caldwell Prize in Chemistry.

šŸ”¬ Dr. Meltzer continued his academic pursuits with a General Electric Fellowship in Chemistry at Harvard and a Dean’s Scholarship at Yale University School of Medicine. Notably, his impactful career includes a Research Scientist Development Award from the National Institute of Mental Health (NIMH) and an Efron Award from the American College of Neuropsychopharmacology. His excellence in academia is further highlighted by the Arthur P. Noyes Award in Schizophrenia from the Commonwealth of Pennsylvania. Dr. Meltzer’s achievements have left an indelible mark on the scientific community, earning him a place in Who’s Who in America. šŸ†šŸ§Ŗ

MembershipsĀ 

Dr. Herbert Y. Meltzer holds prestigious memberships in various esteemed organizations, showcasing his dedication to advancing the field of neuropsychopharmacology and psychiatry. As a distinguished member of the American College of Neuropsychopharmacology, American Psychiatric Association, and the American Association for the Advancement of Science, he contributes to cutting-edge research and practices. His involvement in the Collegium Internationale Neuropsychopharmacologicum, New York Academy of Sciences, Society for Neuroscience, Society of Biological Psychiatry, and the International Society for CNS Clinical Trials and Methodology reflects his global engagement in neuroscientific endeavors. šŸ§ 

These memberships underscore Dr. Meltzer’s commitment to staying at the forefront of scientific developments and collaborating with experts worldwide, reinforcing his impact on advancing our understanding of neuropsychopharmacology and mental health. šŸŒ

Publication top notes

Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study

  • Pharmacogenomics Journal, 23(5):119ā€“126, 2023.
  • Link
  • Citations: 1

Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia

  • Journal of Clinical Psychopharmacology, 43(3):211ā€“219, 2023.
  • Link
  • Citations: 3

Neuroendocrine Studies in Psychiatric Disorders: The Role of Serotonin

  • The Role of Serotonin in Psychiatric Disorders, 2023, pp. 57ā€“90.
  • Link
  • Citations: 7

Role of advanced glycation end products in the longitudinal association between muscular strength and psychotic symptoms among adolescents

Schizophrenia risk loci from xMHC region were associated with antipsychotic response in chronic schizophrenic patients with persistent positive symptom

  • Translational Psychiatry, 12(1):92, 2022.
  • Link
  • Citations: 3

Awareness of illness moderates self-assessment of psychotic symptoms

  • Australian and New Zealand Journal of Psychiatry, 56(10):1287ā€“1294, 2022.
  • Link
  • Citations: 1

Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice

  • Behavioural Brain Research, 432:113964, 2022.
  • Link
  • Citations: 1

 

Lakshmi Rajagopal | Schizophrenia | Best Researcher Award

Dr. Lakshmi Rajagopal | Schizophrenia | Best Researcher Award

Dr. Lakshmi Rajagopal, an accomplished Indian researcher in Neuropsychopharmacology, has earned recognition with the Best Researcher Award for her groundbreaking work in schizophrenia. Holding a Ph.D. from the University of Bradford, UK, her dissertation focused on Neonatal Phencyclidine (PCP) induced deficits in rats, contributing to schizophrenia research. With expertise in behavioral testing and immunohistochemistry, Dr. Rajagopal has made significant contributions during her tenure at Northwestern University, Feinberg School of Medicine, Chicago. Currently a Research Assistant Professor, she has excelled in her roles as a Postdoctoral Research Fellow and Research Associate. A recipient of the O1 visa, she is in the process of obtaining an EB1 visa. Dr. Rajagopal’s career showcases a commitment to advancing our understanding of neuropsychiatric disorders. šŸ†šŸ§ 

Education

Dr. Lakshmi Rajagopal, an esteemed Neuropsychopharmacologist, earned her Ph.D. from the University of Bradford, UK, from 2008 to 2011. Her dissertation, “Neonatal Phencyclidine (PCP) induced deficits in rats,” showcased her expertise in behavioral testing and immunohistochemistry, under the guidance of Prof. Joanna Neill and Dr. Michael Harte at Manchester University. She furthered her academic journey with a Masters in Environmental Protection from Delhi University (1995-1997) and a B.Sc. in Zoology from Womenā€™s Christian College, Chennai (1992-1995). Dr. Rajagopal, dedicated to scientific inquiry, has seamlessly blended her passion for neuroscience and environmental protection. Her academic odyssey is a testament to her commitment to understanding the intricacies of the brain and the environment. šŸ§ šŸ”¬šŸŒæ

Experience

Dr. Lakshmi Rajagopal, a dynamic researcher, has played pivotal roles at Northwestern University’s Feinberg School of Medicine since 2012. As a Postdoctoral Research Fellow (2012-2019) and Research Associate (2019-2022), she excelled in behavioral neuroscience, establishing and managing the Behavioral Core of the laboratory. Dr. Rajagopal, currently a Research Assistant Professor, has expertise in diverse behavioral paradigms and techniques such as Western Blot and immunohistochemistry. Notably, she initiated and produced constitutive and conditioned 5-HT7 knock-out mice, contributing to four ongoing first-author research manuscripts. As the DEA liaison, she manages controlled substances, while overseeing IACUC protocols, grant applications, and supervising interns and candidates. In her prior role as Quality Manager at LG Medical Transcription, she efficiently led a team of 500+ editors/transcriptionists from 1999 to 2003. šŸ§ šŸ”¬šŸ‘©ā€šŸ”¬

Awards and Honors

Dr. Lakshmi Rajagopal is a distinguished researcher recognized with numerous honors. Acknowledged by the United States Army, Navy, and Air Force, she received a certificate for outstanding mentorship of a summer intern at the Junior Science & Humanities Symposium in 2016. Her commitment to excellence garnered the prestigious “Service Excellence Award” from Northwestern University’s Feinberg School of Medicine in 2017. Dr. Rajagopal’s international acclaim includes Travel Awards from the British Association of Pharmacology for poster presentations in 2009 and 2010, as well as full Travel Awards for abstract/poster presentations at CINP in Florence (2010) and ECNP in France (2008). Notably, she was nominated and featured in Marquis Whoā€™s Who as one of the top researchers in America in 2017. šŸ†šŸŒšŸ”¬

Areas of Expertise

Dr. Lakshmi Rajagopal is a distinguished expert in Neuropsychopharmacology, Neuropharmacology, and Behavioral Pharmacology. Her multifaceted expertise encompasses cognition, psychosis, Major Depressive Disorder, Alzheimerā€™s Disease, and the experimental design of animal behavior tests. Specializing in the pharmacology of preclinical models, she excels in statistical analyses, molecular and neuropathological investigations, and the study of neuroinflammation. Dr. Rajagopal’s comprehensive understanding spans the intricate interplay between pharmacological interventions and neural mechanisms, contributing significantly to the fields of neuroscience and psychiatry. šŸ§ šŸ’ŠšŸ­

Publications Top Notes

“The dopamine D1 receptor positive allosteric modulator, DETQ, improves cognition and social interaction in aged mice and enhances cortical and hippocampal acetylcholine efflux.”

“NU-1223, a simplified analog of alstonine, with 5-HT2cR agonist-like activity, rescues memory deficit and positive and negative symptoms in subchronic phencyclidine mouse model of schizophrenia.”

“Repeated Administration of Rapastinel Produces Exceptionally Prolonged Rescue of Memory Deficits in Phencyclidine-Treated Mice.”

“Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia.”

“Depolarizing GABAA current in the prefrontal cortex is linked with cognitive impairment in a mouse model relevant for schizophrenia.”

“Systematic analysis of brain lactate and pH levels in 65 animal models related to neuropsychiatric conditions.”

“The D1 Positive Allosteric Modulator, DETQ, Improves Cognition in Aged Mice and Enhances Cortical and Hippocampal Acetylcholine Efflux.”

“Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action.”

“The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice.”